Page 130 - 2021年17期
P. 130

研究[D].石家庄:河北医科大学,2015.                         [24]  DANDAWATE P,SUBRAMANIAM D,PANOVICH P,
        [11]  张国建,阎庆辉,黄琛,等.葫芦素 B 对人结肠癌细胞株                        et al. Cucurbitacin B and I inhibits colon cancer growth
             LS174-T 的生长抑制作用[J].中华实验外科杂志,2014,                   by targeting the Notch signaling pathway[J]. Sci Rep,
             31(12):2751-2753.                                   2020,10(1):1290.
        [12]  MA W,XIANG Y,YANG R,et al. Cucurbitacin B induces  [25]  CHAN K T,MENG F Y,LI Q,et al. Cucurbitacin B in-
             inhibitory effects via the CIP2A/PP2A/C-KIT signaling  duces apoptosis and S phase cell cycle arrest in BEL-7402
             axis in t(8;21)acute myeloid leukemia[J]. J Pharmacol  human hepatocellular carcinoma cells and is effective via
             Sci,2019,139(4):304-310.                            oral administration[J]. Cancer Lett,2010,294(1):118-
        [13]  YOUSEFI H,VATANMAKANIAN M,MAHDIANNASSER            124.
             M,et al. Understanding the role of integrins in breast can-  [26]  ZHANG M,ZHANG H,SUN C,et al. Targeted constitu-
             cer invasion,metastasis,angiogenesis,and drug resis-  tive activation of signal transducer and activator of tran-
             tance[J]. Oncogene,2021,40(6):1043-1063.            scription 3 in human hepatocellular carcinoma cells by cu-
        [14]  SHANG Y,GUO X X,LI W W,et al. Cucurbitacin B in-   curbitacin B[J]. Cancer Chemother Pharmacol,2009,63
             hibits neuroblastoma cell proliferation through up-regula-  (4):635-642.
             tion of PTEN[J]. Eur Rev Med Pharmacol Sci,2014,18  [27]  GAO Y,ISLAM M S,TIAN J,et al. Inactivation of ATP
             (21):3297-3303.                                     citrate lyase by cucurbitacin B:a bioactive compound
        [15]  ARIBI A,GERY S,LEE D H,et al. The triterpenoid cu-  from cucumber,inhibits prostate cancer growth[J]. Cancer
             curbitacin B augments the antiproliferative activity of che-  Lett,2014,349(1):15-25.
             motherapy in human breast cancer[J]. Int J Cancer,2013,  [28]  ZHANG M,SUN C,SHAN X,et al. Inhibition of pan-
             132(12):2730-2737.                                  creatic cancer cell growth by cucurbitacin B through
        [16]  EL-SENDUNY F F,BADRIA F A,EL-WASEEF A M,et         modulation of signal transducer and activator of transcrip-
             al. Approach for chemosensitization of cisplatin-resistant  tion 3 signaling[J]. Pancreas,2010,39(6):923-929.
             ovarian cancer by cucurbitacin B[J]. Tumour Biol,2016,  [29]  何臣,王菊辉,丘韶校,等.葫芦素 B 抑制 STAT3/Bcl-2 表
             37(1):685-698.                                      达诱导非小细胞肺癌 H1975 细胞凋亡[J].中国实用医
        [17]  WANG X,LI H,LI D,et al. Sorafenib and CuB exert    药,2020,15(13):196-198.
             synergistic antitumor effects against hepatocellular carci-  [30]  YAR SAGLAM A S,ALP E,ELMAZOGLU Z,et al.
             noma cells via inhibition of STAT3 phosphorylation[J].  Treatment with cucurbitacin B alone and in combination
             FEBS Open Bio,2021,11(1):133-145.                   with gefitinib induces cell cycle inhibition and apoptosis
        [18]  WANG X,BAI Y,YAN X,et al. Cucurbitacin B exhibits  via EGFR and JAK/STAT pathway in human colorectal
             antitumor effects on CD133 + HepG2 liver cancer stem  cancer cell lines[J]. Hum Exp Toxicol,2016,35(5):526-
             cells by inhibiting JAK2/STAT3 signaling pathway[J]. An-  543.
             ticancer Drugs,2021,32(5):548-557.             [31]  DING X,CHI J,YANG X,et al. Cucurbitacin B synergis-
        [19]  ALENZI F Q. Links between apoptosis,proliferation and  tically enhances the apoptosis-inducing effect of arsenic
             the cell cycle[J]. Br J Biomed Sci,2004,61(2):99-102.  trioxide by inhibiting STAT3 phosphorylation in lympho-
        [20]  XU J,CHEN Y,YANG R,et al. Cucurbitacin B inhibits  ma Ramos cells[J]. Leuk Lymphoma,2017,58(10):
             gastric cancer progression by suppressing STAT3 activi-  2439-2451.
             ty[J]. Arch Biochem Biophys,2020,684:108314.   [32]  KIM E K,CHOI E J. Compromised MAPK signaling in
        [21]  GARG S,KAUL S C,WADHWA R. Cucurbitacin B and       human diseases:an update[J]. Arch Toxicol,2015,89(6):
             cancer intervention:chemistry,biology and mechanisms:  867-882.
             review[J]. Int J Oncol,2018,52(1):19-37.       [33]  郑倩.葫芦素B对神经母细胞瘤SH-SY5Y细胞的抑制作
        [22]  YASUDA S,YOGOSAWA S,IZUTANI Y,et al. Cucurbi-      用机制研究[D].武汉:华中科技大学,2014.
             tacin B induces G2 arrest and apoptosis via a reactive oxy-  [34]  CHAN K T,LI K,LIU S L,et al. Cucurbitacin B inhibits
             gen species-dependent mechanism in human colon adeno-  STAT3 and the Raf/MEK/ERK pathway in leukemia cell
             carcinoma SW480 cells[J]. Mol Nutr Food Res,2010,54  line K562[J]. Cancer Lett,2010,289(1):46-52.
             (4):559-565.                                   [35]  SILVA I T,GELLER F C,PERSICH L,et al. Cytotoxic ef-
        [23]  GUO J,WU G,BAO J,et al. Cucurbitacin B induced     fects of natural and semisynthetic cucurbitacins on lung
             ATM-mediated DNA damage causes G2/M cell cycle ar-  cancer cell line A549[J]. Invest New Drugs,2016,34
             rest in a ROS-dependent manner[J]. PloS One,2014,9  (2):139-148.
             (2):e88140.                                    [36]  冯杰.葫芦素B联合奥沙利铂调控AKT/mTOR通路诱导


        ·2168 ·  China Pharmacy 2021 Vol. 32 No. 17                                 中国药房    2021年第32卷第17期
   125   126   127   128   129   130   131   132   133   134   135